Cantrust (Far East) Limited Cuts Stake in Hansoh Pharma (03692) by 124,000 Shares at About HK$33.96 Each
Stock News
Oct 05
According to the latest disclosures from the Hong Kong Stock Exchange, on October 2, Cantrust (Far East) Limited reduced its holdings in Hansoh Pharma (ASX: 03692) by 124,000 shares at a price of HK$33.9623 per share, for a total consideration of approximately HK$4.2113 million.
Following the reduction, its latest shareholding stands at approximately 920 million shares, representing 15.16% of the company.
The transaction also involves other related parties: APEX MEDICAL COMPANY LTD., JQC Holding Limited, JQC International Limited, and Cen Junda.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.